Available datapackage for study 'A Phase 1, Open-label Study to Evaluate the Relative Bioavailability of Two Formulations of BIIB074 and to Assess the Effect of Food on BIIB074 Pharmacokinetics in Healthy Subjects'

The primary objectives of the study are to assess the relative bioavailability of the BIIB074
direct compression formulation (DCF) to the BIIB074 roller compaction formulation (RCF) and
to determine the effect of a high-fat meal on the pharmacokinetics (PK) of the BIIB074 DCF.
The secondary objective of the study is to assess the safety and tolerability of BIIB074
administered as the DCF following single oral dose administration in healthy participants.